To evaluate the metabolic changes on ¹⁸F-fluoro-2-deoxyglucose positron emission tomography integrated with computed tomography (¹⁸ F-FDG PET-CT) performed before, during and after concurrent chemo-radiotherapy in patients with locally advanced non-small cell lung cancer (NSCLC); to correlate the metabolic response with the delivered radiation dose and with the clinical outcome.
Massaccesi, M., Calcagni, M. L., Spitilli, M. G., Cocciolillo, F., Pelligrò, F., Bonomo, L., Valentini, V., Giordano, A., ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose, <<RADIATION ONCOLOGY>>, 2012; 7 (N/A): 106-106. [doi:10.1186/1748-717X-7-106] [http://hdl.handle.net/10807/37831]
¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose
Massaccesi, Mariangela;Calcagni, Maria Lucia;Spitilli, Maria Grazia;Cocciolillo, Fabrizio;Pelligrò, F;Bonomo, Lorenzo;Valentini, Valeria;Giordano, Alessandro
2012
Abstract
To evaluate the metabolic changes on ¹⁸F-fluoro-2-deoxyglucose positron emission tomography integrated with computed tomography (¹⁸ F-FDG PET-CT) performed before, during and after concurrent chemo-radiotherapy in patients with locally advanced non-small cell lung cancer (NSCLC); to correlate the metabolic response with the delivered radiation dose and with the clinical outcome.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
